ICO Therapeutics Inc - Company & Market Research Reports

iCo Therapeutics is a Canada-based biotechnology company principally focused on the identification, development and commercialization of drug candidates to treat sight-and life-threatening diseases. Its business model aims to acquire the rights to drugs that are either off-patent, currently approved or near commercialization and develop them. The company's product candidates include iCo-007, iCo-008 and an Oral Amphotericin B (Amp B) Delivery System.

From
From
From
From
From
From
From
From
Psoriasis - Pipeline Review, H2 2018 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 726 Pages
From
Psoriasis - Pipeline Review, H1 2018 - Product Thumbnail Image

Psoriasis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 709 Pages
From
From
Atopic Dermatitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 379 Pages
From
Ulcerative Colitis - Pipeline Review, H2 2018 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 542 Pages
From
Ulcerative Colitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 482 Pages
From
From
From
Allergic Rhinitis - Pipeline Review, H2 2018 - Product Thumbnail Image

Allergic Rhinitis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 141 Pages
From
From
Asthma - Pipeline Review, H2 2018 - Product Thumbnail Image

Asthma - Pipeline Review, H2 2018

  • Drug Pipelines
  • 639 Pages
From
Loading Indicator
adroll